ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, cilt.62, 2006 (SCI-Expanded)
This study of the title compound, C14H9F3N4O, is part of a series of structural investigations of cyclooxygenase-2 (COX-2) inhibitors containing 1,3-diarylpyrazole derivatives. The crystal structure is stabilized by intermolecular N-H center dot center dot center dot O and C-H center dot center dot center dot F hydrogen-bonding interactions.